Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tania Monzón Vazquez"'
Autor:
Yanet Parodis López, Tania Monzón Vazquez, Francisco Valga, Francisco Alonso Alman, Juan Francisco Betancor Jiménez, Sebastian Hillebrand Ortega, Fernando Henríquez Palop, Gloria Anton Pérez
Publikováno v:
Nefrología, Vol 40, Iss 4, Pp 485-486 (2020)
Externí odkaz:
https://doaj.org/article/71bc9225db644d48b1af8ba1bb5fd4f8
Autor:
Yanet Parodis López, Tania Monzón Vazquez, Francisco Valga, Francisco Alonso Alman, Juan Francisco Betancor Jiménez, Sebastian Hillebrand Ortega, Fernando Henríquez Palop, Gloria Anton Pérez
Publikováno v:
Nefrología (English Edition). 40:485-486
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c1a39f44a5cef867dc7d4001b7e9f25d
https://doi.org/10.1016/j.nefroe.2019.08.009
https://doi.org/10.1016/j.nefroe.2019.08.009
Autor:
José C. De la Flor, Javier Deira Lorenzo, Alexander Marschall, Francisco Valga, Tania Monzón Vázquez, Elisa Ruiz Cícero
Publikováno v:
Case Reports in Nephrology and Dialysis, Vol 12, Iss 3, Pp 238-247 (2022)
The glucagon-like peptide-1 receptor agonists (GLP-1RA) are among the newest treatment options available for managing of type 2 diabetes mellitus and slowing the progression of diabetes kidney disease (DKD). Subcutaneous (SC) semaglutide (Ozempic®)
Externí odkaz:
https://doaj.org/article/cb118a60f41f436c9a65d9d7c7c97203